Intervention

Singulair

ClinicalTrials.gov intervention label

Clinical trials6

Recruiting0

Common conditions1

Lead sponsors shown3

Clinical trials

6 shown

Safety and Efficacy of YHD001 in AsthmaNCT01424124 · 2011-11-01

Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fasted ConditionsNCT01659905 · 2008-08-01

Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fed ConditionsNCT01659892 · 2008-08-01

Bioequivalency Study of Montelukast 10 mg Tablets Under Fasted ConditionsNCT01659931 · 2008-02-01

Bioequivalency Study of Montelukast 10 mg Tablets Under Fed ConditionsNCT01659918 · 2008-02-01

Study With GW274150 In Patients With Mild AsthmaNCT00273013 · 2004-11-15

Common conditions

Leading sponsors

Roxane Laboratories4 GlaxoSmithKline1 Yuhan Corporation1

Trial status mix

COMPLETED6

Phase mix

EARLY_PHASE14

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.